Fortis Healthcare Share Price
₹629.55 -10.45 (-1.63%)
22 Jan, 2025 12:22
Start SIP in FORTIS
Start SIPPerformance
- Low
- ₹625
- High
- ₹642
- 52 Week Low
- ₹375
- 52 Week High
- ₹745
- Open Price₹641
- Previous Close₹640
- Volume862,346
Investment Returns
- Over 1 Month -7.1%
- Over 3 Month + 3.51%
- Over 6 Month + 30.81%
- Over 1 Year + 50.29%
Smart Investing Starts Here Start SIP with Fortis Healthcare for Steady Growth!
Fortis Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 72.5
- PEG Ratio
- 3.7
- Market Cap Cr
- 47,528
- P/B Ratio
- 6.1
- Average True Range
- 24.38
- EPS
- 9.16
- Dividend Yield
- 0.2
- MACD Signal
- -1.75
- RSI
- 37.86
- MFI
- 40.76
Fortis Healthcare Financials
Fortis Healthcare Technicals
EMA & SMA
Current Price
₹629.55
-10.45
(-1.63%)
- Bearish Moving Average 13
- Bullish Moving Average 3
- 20 Day
- ₹678.36
- 50 Day
- ₹671.63
- 100 Day
- ₹636.26
- 200 Day
- ₹573.52
Resistance and Support
645.7
- R3 676.75
- R2 668.30
- R1 654.15
- S1 631.55
- S2 623.10
- S3 608.95
Fortis Healthcare Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2024-11-08 | Quarterly Results | |
2024-10-09 | Others | Inter alia, to consider and approve the issue of Non-Convertible Debentures (NCD). per share(10%)Final Dividend |
2024-08-30 | To consider Fund Raising | |
2024-08-06 | Quarterly Results | |
2024-05-23 | Audited Results & Final Dividend |
Fortis Healthcare F&O
About Fortis Healthcare
- NSE Symbol
- FORTIS
- BSE Symbol
- 532843
- Managing Director & CEO
- Dr. Ashutosh Raghuvanshi
- ISIN
- INE061F01013
Similar Stocks to Fortis Healthcare
Fortis Healthcare FAQs
Fortis Healthcare share price is ₹629 As on 22 January, 2025 | 12:08
The Market Cap of Fortis Healthcare is ₹47528.4 Cr As on 22 January, 2025 | 12:08
The P/E ratio of Fortis Healthcare is 72.5 As on 22 January, 2025 | 12:08
The PB ratio of Fortis Healthcare is 6.1 As on 22 January, 2025 | 12:08
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.